US 10745413
Commercially viable synthesis of cantharidin and bioactive cantharidin derivatives
granted A61KA61K31/381A61P
Quick answer
US patent 10745413 (Commercially viable synthesis of cantharidin and bioactive cantharidin derivatives) held by Verrica Pharmaceuticals Inc. expires Mon Aug 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Verrica Pharmaceuticals Inc.
- Grant date
- Tue Aug 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 34
- CPC classes
- A61K, A61K31/381, A61P, A61P11/02, A61P15/00